Zobrazeno 1 - 10 of 455 pro vyhledávání: '"J P Galmiche"'
3
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies
Autor: Jan Gunnar Hatlebakk, M. Jahreskog, Roberto Fiocca, Stephen Attwood, C. Ell, Göran Långström, Stefan Eklund, J. P. Galmiche, B. Hasselgren, Tore Lind, Lars Lundell
Publikováno v: Alimentary Pharmacology & Therapeutics. 41:1162-1174
SummaryBackground Control of chronic gastro-oesophageal reflux disease may be achieved either by anti-reflux surgery (ARS) or by long-term medical therapy with proton pump inhibitors (PPIs). The primary efficacy results of the SOPRAN study, comparing
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aeb5b768987198e41bfe353212171c7
https://doi.org/10.1111/apt.13194
Zobrazit plný text záznamu
5
RDP58, a Novel Immunomodulatory Peptide with Anti-Inflammatory Effects. A Pharmacological Study in Trinitrobenzene Sulphonic Acid Colitis and Crohn Disease
Autor: M. Doubremelle, Jean-Pierre Segain, D. Raingeard de la Blétière, C. Toquet, J. P. Galmiche, R. Buelow, Arnaud Bourreille
Publikováno v: Scandinavian journal of gastroenterology. 38(5)
Tumour necrosis factor (TNF) plays a key role in the pathogenesis of Crohn disease (CD). RDP58 is a novel anti-inflammatory decapeptide which was developed using a novel rational design strategy. Recently, RDP58 has proved to be a potent inhibitor of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57434416a031d3a73a38edbad0098f5f
https://pubmed.ncbi.nlm.nih.gov/28443774
Zobrazit plný text záznamu
7
Diagnosis and treatment of chronic constipation - a European perspective
Autor: Guy E. Boeckxstaens, Vincenzo Stanghellini, J. P. Galmiche, Michael Fried, Jan Tack, Stefan Müller-Lissner, Magnus Simren, Michael A. Kamm
Publikováno v: Neurogastroenterology & Motility. 23:697-710
Background Although constipation can be a chronic and severe problem, it is largely treated empirically. Evidence for the efficacy of some of the older laxatives from well-designed trials is limited. Patients often report high levels of dissatisfacti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::373b478bc05ba611cf4aeecdcd00cc77
https://doi.org/10.1111/j.1365-2982.2011.01709.x
Zobrazit plný text záznamu
8
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease
Autor: François Mion, Jan Tack, Sabine Roman, J. P. Galmiche, S. Bruley des Varannes, Charlotte Keywood, Peter Malfertheiner, Radu Tutuian, F. Zerbib
Publikováno v: Alimentary Pharmacology & Therapeutics. 33:911-921
Aliment Pharmacol Ther 2011; 33: 911–921 Summary Background ADX10059, a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator, has been shown to reduce gastro-oesophageal reflux events and oesophageal acid exposure in patients wi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca0fe7005c3f95b556bc0155dadef076
https://doi.org/10.1111/j.1365-2036.2011.04596.x
Zobrazit plný text záznamu
10
In vivo real-time imaging of human duodenal mucosal structures in celiac disease using endocytoscopy
Autor: Jean-François Mosnier, Emmanuel Coron, M Le Rhun, Haruhiro Inoue, Tamara Matysiak-Budnik, J. P. Galmiche
Publikováno v: Endoscopy. 42:191-196
Background and aims Celiac disease is a gluten-induced enteropathy whose diagnosis is based on histological evidence of villous atrophy. The diagnosis may be difficult if the orientation of histological sections is other than optimal. During upper ga
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ad1a809a72afe262524c2bac76b447f
https://doi.org/10.1055/s-0029-1243838
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje